Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 30 of 1714:
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, beta 4 subunit THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TANNIC ACID CYP450-2C9 Inhibition 91% 4.6074uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TANNIC ACID CYP450-2C9 Inhibition 91% 4.6074uM NoneNone View
A3 adenosine receptor ZAFIRLUKAST Adenosine A3 91% 1.363uM .77uM View
lymphocyte protein tyrosine kinase (mapped) BITHIONOL Protein Tyrosine Kinase, Lck 91% 2.255uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) BENZTROPINE Adrenergic alpha1D 91% .052uM .026uM View
adrenergic receptor, alpha 1a CINNARIZINE Adrenergic alpha1A 91% 1.919uM .777uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PEMOLINE Dopamine Transporter 91% .5213uM .4142uM View
adrenergic receptor, alpha 1b FLUNARIZINE Adrenergic alpha1B 91% 1.096uM .606uM View
angiotensin 1 converting enzyme 1 QUINAPRIL Protease, Angiotensin Converting Enzyme 91% 4.008uM NoneNone View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 QUINAPRIL Protease, Angiotensin Converting Enzyme 91% 4.008uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) QUETIAPINE Adrenergic alpha1D 91% .0966uM .0475uM View
opioid receptor, sigma 1 TERBINAFINE Sigma1 91% .5602uM .2354uM View
cholinergic receptor, muscarinic 1 TERCONAZOLE Muscarinic M1 91% 5.709uM 1.375uM View
arachidonate 15-lipoxygenase, second type TERCONAZOLE Lipoxygenase 15-LO 91% 2.446uM NoneNone View
arachidonate 15-lipoxygenase TERCONAZOLE Lipoxygenase 15-LO 91% 2.446uM NoneNone View
arachidonate 15-lipoxygenase TERCONAZOLE Lipoxygenase 15-LO 91% 2.446uM NoneNone View
adrenergic receptor, alpha 2a SEMUSTINE Imidazoline I2, Central 91% 1.615uM 1.077uM View
adrenergic receptor, alpha 2c (Non-specific probe) SEMUSTINE Imidazoline I2, Central 91% 1.615uM 1.077uM View
adrenergic receptor, alpha 1a PENTAMIDINE Adrenergic alpha1A 91% 1.212uM .491uM View
adrenergic receptor, alpha 1d (Non-specific probe) METERGOLINE Adrenergic alpha1D 91% .136uM .067uM View
cholinergic receptor, muscarinic 4 PROCHLORPERAZINE Muscarinic M4 91% 1.363uM .19uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) FLUVASTATIN CYP450-2C9 Inhibition 91% .4uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 FLUVASTATIN CYP450-2C9 Inhibition 91% .4uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CYPROHEPTADINE Adrenergic, Norepinephrine Transporter 91% .564uM .559uM View
opioid receptor, sigma 1 NOVARTIS P-38 INHIBITOR Sigma1 91% .7951uM .3342uM View
adenosine A2a receptor ECONAZOLE Adenosine A2A 91% 14.616uM 8.206uM View
Cytochrom P450-1A2 monooxygenase ECONAZOLE CYP450-1A2 Inhibition 91% .3uM NoneNone View
dopamine receptor D4 MICONAZOLE Dopamine D4.2 91% 15.27uM 5.354uM View
melanocortin 4 receptor MICONAZOLE Melanocortin MC4 91% 12.448uM 11.97uM View
prostaglandin-endoperoxide synthase 2 INDOMETHACIN Cyclooxygenase COX-2 91% .84uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) INDOMETHACIN Cyclooxygenase COX-2 91% .84uM NoneNone View
cholinergic receptor, muscarinic 4 DEXCHLORPHENIRAMINE Muscarinic M4 91% 1.976uM .276uM View
adrenergic receptor, alpha 2b DEXCHLORPHENIRAMINE Adrenergic alpha2B 91% 4.607uM 2.103uM View
5-hydroxytryptamine (serotonin) receptor 2B SULCONAZOLE Serotonin 5-HT2B 91% 3.02uM 1.922uM View
adrenergic receptor, alpha 2a SULCONAZOLE Adrenergic alpha2A 91% 4.043uM 1.516uM View
5-hydroxytryptamine (serotonin) receptor 2A LY-294002 Serotonin 5-HT2A 91% 2.796uM .799uM View
progesterone receptor MEDROXYPROGESTERONE Progesterone 91% .711uM .093uM View
thromboxane A synthase 1 HEXACHLOROPHENE Thromboxane Synthetase 91% 3.087uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) HEXACHLOROPHENE Thromboxane Synthetase 91% 3.087uM NoneNone View
Sigma-2 Receptor SULOCTIDIL Sigma2 91% .0214uM .0132uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 SULOCTIDIL Dopamine Transporter 91% 2.57uM 2.0419uM View
Cytochrom P450-2D6 monooxygenase 1,3-DIPHENYLGUANIDINE CYP450-2D6 Inhibition 91% 3.4443uM NoneNone View
sodium channel, voltage-gated, type IV, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel associated protein 1 PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel associated protein 2 PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type III, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type I, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type IX, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type VII, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
amiloride-sensitive cation channel 5, intestinal PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type III, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type XI, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type I, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type II, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1 alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1 gamma PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1 beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type XI, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1, gamma PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1, delta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, nonvoltage-gated 1 alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type X, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type IX, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage gated, type VIII, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type VII, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type IV, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type IV, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type III, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type II, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type II, alpha 2 PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type I, beta PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
sodium channel, voltage-gated, type I, alpha PROPAFENONE Sodium Channel, Site 2 91% 1.299uM 1.185uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 FLUNARIZINE Serotonin Transporter 91% .499uM .265uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 THIORIDAZINE Serotonin Transporter 91% .751uM .399uM View
5-hydroxytryptamine (serotonin) receptor 2B CYCLIZINE Serotonin 5-HT2B 91% .373uM .238uM View
5-hydroxytryptamine (serotonin) receptor 2A DIMENHYDRINATE Serotonin 5-HT2A 91% .693uM .198uM View
5-hydroxytryptamine (serotonin) receptor 2A PROPAFENONE Serotonin 5-HT2A 91% .654uM .187uM View
cholinergic receptor, muscarinic 5 FLUNARIZINE Muscarinic M5 91% 1.107uM .795uM View
cholinergic receptor, muscarinic 3 CYCLIZINE Muscarinic M3 91% .748uM .159uM View
cholinergic receptor, muscarinic 3 CINNARIZINE Muscarinic M3 91% .762uM .162uM View
cholinergic receptor, muscarinic 2 CYCLIZINE Muscarinic M2 91% 1.158uM .412uM View
calcium channel, voltage-dependent, gamma subunit 3 PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, gamma subunit 2 PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, gamma subunit 1 PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, beta 4 subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, beta 3 subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, beta 2 subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, alpha 1F subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROPAFENONE Calcium Channel Type L, Phenylalkylamine 91% 1.744uM 1.695uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 8 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 7 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 6 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 5 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 4 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 3 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
calcium channel, voltage-dependent, gamma subunit 2 OXICONAZOLE Calcium Channel Type L, Dihydropyridine 90% 1.4711uM .9457uM View
prostaglandin-endoperoxide synthase 1 OXAPROZIN Cyclooxygenase COX-1 90% .856uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) OXAPROZIN Cyclooxygenase COX-1 90% .856uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A OXYMETAZOLINE Serotonin 5-HT2A 90% 1.285uM .367uM View
Cytochrom P450-1A2 monooxygenase TANNIC ACID CYP450-1A2 Inhibition 90% .919uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) EBASTINE Adrenergic alpha1D 90% 1.7712uM .8706uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 FLUNARIZINE Adrenergic, Norepinephrine Transporter 90% 1.339uM 1.328uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TERFENADINE Adrenergic, Norepinephrine Transporter 90% 1.928uM 1.912uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 THIORIDAZINE Adrenergic, Norepinephrine Transporter 90% 1.551uM 1.538uM View
adenosine A2a receptor RALOXIFENE Adenosine A2A 90% 2.111uM 1.185uM View
adrenergic receptor, alpha 1a RALOXIFENE Adrenergic alpha1A 90% 2.204uM .892uM View
Sigma-2 Receptor RALOXIFENE Sigma2 90% .385uM .237uM View
thromboxane A synthase 1 CANDESARTAN Thromboxane Synthetase 90% 3.0594uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) CANDESARTAN Thromboxane Synthetase 90% 3.0594uM NoneNone View
mitogen activated protein kinase 14 TRIBROMSALAN Protein Serine/Threonine Kinase, p38alpha 90% .715uM NoneNone View
mitogen-activated protein kinase 14 TRIBROMSALAN Protein Serine/Threonine Kinase, p38alpha 90% .715uM NoneNone View
adrenergic receptor, alpha 2a ASTEMIZOLE Adrenergic alpha2A 90% 4.846uM 1.817uM View
carbonic anhydrase VIII CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase VII CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase VA, mitochondrial CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase IV CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase III, muscle specific CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase I CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase XIV CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase VB, mitochondrial CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase XII CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase VI CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
carbonic anhydrase II CHLORTHALIDONE Carbonic Anhydrase 90% .677uM NoneNone View
adrenergic receptor, alpha 2b BRIMONIDINE Adrenergic alpha2B 90% 1.047uM .478uM View
adrenergic receptor, alpha 1d (Non-specific probe) CLOMIPRAMINE Adrenergic alpha1D 90% .18uM .088uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 CLOZAPINE Serotonin Transporter 90% .546uM .29uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CARVEDILOL Adrenergic, Norepinephrine Transporter 90% .538uM .533uM View
5-hydroxytryptamine (serotonin) receptor 2B CLOZAPINE Serotonin 5-HT2B 90% .011uM .00718uM View
histamine receptor H 2 CLEMASTINE Histamine H2 90% .37uM .364uM View
mu-opioid receptor MOR BENZOTHIAZYL DISULFIDE Opiate mu 90% 3.113uM 1.264uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 FLUOXETINE Adrenergic, Norepinephrine Transporter 90% 1.303uM 1.292uM View
cholinergic receptor, muscarinic 3 FLUPHENAZINE Muscarinic M3 90% 4.728uM 1.002uM View
Protein-tyrosine kinase, Fyn FLUPHENAZINE Protein Tyrosine Kinase, Fyn 90% 7.99uM NoneNone View
Protein-tyrosine kinase, Fyn CAFFEIC ACID PHENETHYL ESTER Protein Tyrosine Kinase, Fyn 90% 4.214uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 7 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 6 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 5 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 4 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 3 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 2 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, gamma subunit 1 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, beta 4 subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, beta 3 subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, beta 2 subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, alpha 1F subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, beta 1 subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DOXEPIN Calcium Channel Type L, Phenylalkylamine 90% .535uM .52uM View
adrenergic receptor, alpha 1a TRAZODONE Adrenergic alpha1A 90% .117uM .047uM View
adrenergic receptor, beta 1 R-(+)-PROPRANOLOL Adrenergic beta1 90% .37uM .214uM View
adrenergic, beta-1-, receptor R-(+)-PROPRANOLOL Adrenergic beta1 90% .37uM .214uM View
Cytochrom P450-2C19 monooxygenase LANSOPRAZOLE CYP450-2C19 Inhibition 90% .3367uM NoneNone View
opioid receptor, kappa 1 GENTIAN VIOLET Opiate kappa 90% 1.54uM .616uM View
5-hydroxytryptamine (serotonin) receptor 2A GENTIAN VIOLET Serotonin 5-HT2A 90% 2.627uM .751uM View
tachykinin receptor 2 VINORELBINE Tachykinin NK2 90% 1.6062uM .53555uM View
calcium channel, voltage-dependent, gamma subunit 8 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 7 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 6 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 5 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 4 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 3 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 2 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, gamma subunit 1 LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, beta 4 subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, beta 3 subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, beta 2 subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, alpha 1F subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit LOPERAMIDE Calcium Channel Type L, Phenylalkylamine 90% .589uM .573uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type IV, beta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type IV, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type III, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type II, beta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type II, alpha 2 AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type I, beta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type I, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type IV, beta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel associated protein 1 AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View